← European Medicine Shortage Tracker · all medicines
Availability information only — Mobi Doctor doesn't sell medicines; check with a pharmacy.
Doxorubicina cloridrato currently has availability issues reported in 1 European register: Italy.
Shortage ATC — · also listed as: DOXORUBICINA CLORIDRATO · data refreshed 13 September 2026
As of 13 September 2026, 1 of the 9 tracked registers list current availability issues for Doxorubicina cloridrato, covering 10 affected product presentations. The longest-running open report was filed in Italy on 2023-08-31 and has now been open for about 37 months. Where agencies state a cause, manufacturing problems lead with 7 of the 10 stated-cause reports, followed by commercial decisions or discontinuation with 2. Momentum is current, not historical: 6 of the open reports were filed within the last 90 days. Registers in Italy indicate that alternatives or equivalents are available — a pharmacist or doctor can advise on switching.
| Where | Status & products | Since | Expected end | Reason / alternatives | Source |
|---|---|---|---|---|---|
| 🇮🇹 Italy | Shortage ADRIBLASTINA + 9 more productsADRIBLASTINA ADRIBLASTINA CAELYX PEGYLATED LIPOSOMAL DOXORUBICINA ACCORD HEALTHCARE ITALIA DOXORUBICINA ACCORD HEALTHCARE ITALIA DOXORUBICINA ACCORD HEALTHCARE ITALIA DOXORUBICINA AUROBINDO DOXORUBICINA AUROBINDO ZOLSKETIL PEGYLATED LIPOSOMAL | 2023-08-31 | — | Problemi produttivi Alternatives: AIFA: import of a foreign equivalent can be authorised. | register ↗ |
Every individual register entry for Doxorubicina cloridrato in the tracked sources, newest first — including resolved and discontinued reports.
| Reg. | Product | Status | Reported | Expected end | Stated reason |
|---|---|---|---|---|---|
| 🇮🇹 IT | ADRIBLASTINA | Shortage | 2027-01-19 | — | Problemi produttivi |
| 🇮🇹 IT | ADRIBLASTINA | Shortage | 2026-11-10 | — | Problemi produttivi |
| 🇮🇹 IT | ADRIBLASTINA | Shortage | 2026-10-27 | — | Problemi produttivi |
| 🇮🇹 IT | DOXORUBICINA AUROBINDO | Shortage | 2026-10-09 | — | Elevata richiesta/problemi produttivi |
| 🇮🇹 IT | DOXORUBICINA ACCORD HEALTHCARE ITALIA | Shortage | 2026-10-01 | — | Motivi commerciali |
| 🇮🇹 IT | DOXORUBICINA ACCORD HEALTHCARE ITALIA | Shortage | 2026-09-30 | — | Motivi commerciali |
| 🇮🇹 IT | CAELYX PEGYLATED LIPOSOMAL | Shortage | 2026-06-08 | — | Problemi produttivi: distribuzione contingentata |
| 🇮🇹 IT | DOXORUBICINA AUROBINDO | Shortage | 2026-05-07 | — | Problemi produttivi |
| 🇮🇹 IT | ZOLSKETIL PEGYLATED LIPOSOMAL | Shortage | 2025-02-27 | — | Problemi produttivi |
| 🇮🇹 IT | DOXORUBICINA ACCORD HEALTHCARE ITALIA | Shortage | 2023-08-31 | — | Elevata richiesta |
Yes. As of 13 September 2026, availability issues are reported in: Italy. Availability is national — a shortage in one country does not mean it is short everywhere.
10 of the active register entries indicate alternatives or equivalents (same active substance or an alternative treatment). Do not switch on your own — a pharmacist or prescriber can confirm the right substitute in your country.
Directly from the official medicines-agency register that lists Doxorubicina cloridrato: AIFA (Italy). Every row on this page links to the underlying official record, and the dataset is refreshed from the primary sources every morning. Cross-language matching groups the same active substance across registers, so national spellings all resolve to this page.
Pharmacies, patient sites and newsrooms are welcome to embed the live status of Doxorubicina cloridrato — free, with attribution. Copy this snippet:
<iframe src="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/doxorubicina-cloridrato/embed.html" width="100%" height="150" loading="lazy" style="border:1px solid #e1e0d9;border-radius:12px" title="Doxorubicina cloridrato availability in Europe"></iframe> <p style="font-size:12px">Source: <a href="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/doxorubicina-cloridrato/">Doxorubicina cloridrato shortage status — European Medicine Shortage Tracker</a> by MobiDoctor</p>